Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)
2,371.00
+601.00 (33.95%)
Apr 3, 2026, 1:44 PM IDT
TLV:TKUN Market Cap
TLV:TKUN has a market cap or net worth of 20.15 million as of April 2, 2026. Its market cap has decreased by -32.90% in one year.
Market Cap
20.15M
Enterprise Value
28.40M
Revenue
34.95M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,371.00
Market Cap Chart
Since March 17, 2010, TLV:TKUN's market cap has decreased from 22.23B to 20.15M, a decrease of -99.91%. That is a compound annual growth rate of -35.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 3, 2026 | 20.15M | 0.04% |
| Dec 31, 2025 | 20.14M | -28.70% |
| Dec 31, 2024 | 28.24M | 10.79% |
| Dec 31, 2023 | 25.49M | -41.22% |
| Dec 29, 2022 | 43.36M | -59.63% |
| Dec 30, 2021 | 107.40M | -42.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 110.38B |
| Danel (Adir Yeoshua) | 2.64B |
| BrainsWay | 1.72B |
| Kamada | 1.50B |
| Evogene | 24.72M |
| Erika Carmel-Tech | 21.04M |
| Can-Fite BioPharma | 20.57M |
| XTL Biopharmaceuticals | 19.87M |